CD274 and neoplasm: This metabolic reprogramming creates an immunosuppressive niche by simultaneously dampening the cytotoxic activity of infiltrating CD8+T cells and stimulating the surface expression of PD-L1 on tumor cells, thereby enabling the cancer cells to escape immune surveillance210.